Pharma Bio Serv Stock Buy Hold or Sell Recommendation
| PBSV Stock | USD 0.55 0.06 9.84% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Pharma Bio Serv is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Pharma Bio Serv given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Pharma Bio Serv, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Pharma Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Pharma and provide practical buy, sell, or hold advice based on investors' constraints. Pharma Bio Serv. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in state.
Pharma |
Execute Pharma Bio Buy or Sell Advice
The Pharma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pharma Bio Serv. Macroaxis does not own or have any residual interests in Pharma Bio Serv or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pharma Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Pharma Bio Trading Alerts and Improvement Suggestions
| Pharma Bio Serv generated a negative expected return over the last 90 days | |
| Pharma Bio Serv has high historical volatility and very poor performance | |
| Pharma Bio Serv has some characteristics of a very speculative penny stock | |
| About 65.0% of the company outstanding shares are owned by corporate insiders |
Pharma Bio Returns Distribution Density
The distribution of Pharma Bio's historical returns is an attempt to chart the uncertainty of Pharma Bio's future price movements. The chart of the probability distribution of Pharma Bio daily returns describes the distribution of returns around its average expected value. We use Pharma Bio Serv price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pharma Bio returns is essential to provide solid investment advice for Pharma Bio.
| Mean Return | 0.01 | Value At Risk | -9.37 | Potential Upside | 16.67 | Standard Deviation | 6.71 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pharma Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Pharma Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pharma Bio or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pharma Bio's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pharma otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | 1.32 | |
σ | Overall volatility | 6.81 | |
Ir | Information ratio | -0.01 |
Pharma Bio Volatility Alert
Pharma Bio Serv is displaying above-average volatility over the selected time horizon. Pharma Bio Serv is a potential penny stock. Although Pharma Bio may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Pharma Bio Serv. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Pharma instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Pharma Bio Fundamentals Vs Peers
Comparing Pharma Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pharma Bio's direct or indirect competition across all of the common fundamentals between Pharma Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pharma Bio or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pharma Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pharma Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pharma Bio to competition |
| Fundamentals | Pharma Bio | Peer Average |
| Return On Equity | 0.0568 | -0.31 |
| Return On Asset | 0.033 | -0.14 |
| Profit Margin | 0.05 % | (1.27) % |
| Operating Margin | 0.06 % | (5.51) % |
| Current Valuation | 4.87 M | 16.62 B |
| Shares Outstanding | 22.95 M | 571.82 M |
| Shares Owned By Insiders | 64.53 % | 10.09 % |
| Price To Earning | 10.00 X | 28.72 X |
| Price To Book | 1.15 X | 9.51 X |
| Price To Sales | 0.90 X | 11.42 X |
| Revenue | 19.4 M | 9.43 B |
| Gross Profit | 4.88 M | 27.38 B |
| EBITDA | 1.23 M | 3.9 B |
| Net Income | 1.01 M | 570.98 M |
| Cash And Equivalents | 14.24 M | 2.7 B |
| Cash Per Share | 0.62 X | 5.01 X |
| Total Debt | 520.77 K | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 9.07 X | 2.16 X |
| Book Value Per Share | 0.72 X | 1.93 K |
| Cash Flow From Operations | 592.46 K | 971.22 M |
| Earnings Per Share | 0.04 X | 3.12 X |
| Target Price | 1.77 | |
| Number Of Employees | 140 | 18.84 K |
| Beta | 0.36 | -0.15 |
| Market Capitalization | 20.88 M | 19.03 B |
| Total Asset | 20.65 M | 29.47 B |
| Retained Earnings | 20.5 M | 9.33 B |
| Working Capital | 20.6 M | 1.48 B |
| Current Asset | 22.27 M | 9.34 B |
| Current Liabilities | 1.67 M | 7.9 B |
| Z Score | 24.0 | 8.72 |
| Annual Yield | 0.06 % |
Pharma Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pharma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.9 | |||
| Day Median Price | 0.55 | |||
| Day Typical Price | 0.55 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.06) |
About Pharma Bio Buy or Sell Advice
When is the right time to buy or sell Pharma Bio Serv? Buying financial instruments such as Pharma OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Pharma Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Most Shorted Equities Thematic Idea Now
Most Shorted Equities
Dynamically calculated list of top equities currently trending upward via a buy-out by investors. The Most Shorted Equities theme has 211 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Most Shorted Equities Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Pharma OTC Stock Analysis
When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.